GWS
PFE icon

Greykasell Wealth Strategies’s Pfizer PFE Stock Holding History

Greykasell Wealth Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9K Buy
1,614
+304
+23% +$7.95K 0.01% 250
2026
Q1 		$36.8K Hold
1,310
– – 0.01% 270
2025
Q4 		$32.6K Sell
1,310
-545
-29% -$13.7K 0.01% 272
2025
Q3 		$47.3K Sell
1,855
-1,939
-51% -$47.9K 0.02% 208
2025
Q2 		$92K Buy
3,794
+1,005
+36% +$23.4K 0.04% 164
2025
Q1 		$70.7K Buy
+2,789
New +$73K 0.04% 165

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Greykasell Wealth Strategies's PFE Position: Q2 2026 in Review

Greykasell Wealth Strategies increased its Pfizer (PFE) stake by 23% in Q2 2026, buying an estimated $7.95K and bringing the position to 1,614 shares worth $38.9K. The position accounts for 0.01% of the portfolio, ranked #250.

Greykasell Wealth Strategies first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $92K in Q2 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Greykasell Wealth Strategies held 1,614 shares of Pfizer worth $38.9K as of Q2 2026.
  • Greykasell Wealth Strategies bought 304 Pfizer shares in Q2 2026, an estimated $7.95K.
  • Pfizer made up 0.01% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #250 holding.
  • Greykasell Wealth Strategies first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • Greykasell Wealth Strategies's Pfizer position peaked at $92K in Q2 2025.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.